| UniProt ID | LBP_HUMAN | |
|---|---|---|
| UniProt AC | P18428 | |
| Protein Name | Lipopolysaccharide-binding protein | |
| Gene Name | LBP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 481 | |
| Subcellular Localization | Secreted . Cytoplasmic granule membrane . Membrane-associated in polymorphonuclear Leukocytes (PMN) granules. | |
| Protein Description | Plays a role in the innate immune response. Binds to the lipid A moiety of bacterial lipopolysaccharides (LPS), a glycolipid present in the outer membrane of all Gram-negative bacteria. [PubMed: 7517398] | |
| Protein Sequence | MGALARALPSILLALLLTSTPEALGANPGLVARITDKGLQYAAQEGLLALQSELLRITLPDFTGDLRIPHVGRGRYEFHSLNIHSCELLHSALRPVPGQGLSLSISDSSIRVQGRWKVRKSFFKLQGSFDVSVKGISISVNLLLGSESSGRPTVTASSCSSDIADVEVDMSGDLGWLLNLFHNQIESKFQKVLESRICEMIQKSVSSDLQPYLQTLPVTTEIDSFADIDYSLVEAPRATAQMLEVMFKGEIFHRNHRSPVTLLAAVMSLPEEHNKMVYFAISDYVFNTASLVYHEEGYLNFSITDDMIPPDSNIRLTTKSFRPFVPRLARLYPNMNLELQGSVPSAPLLNFSPGNLSVDPYMEIDAFVLLPSSSKEPVFRLSVATNVSATLTFNTSKITGFLKPGKVKVELKESKVGLFNAELLEALLNYYILNTFYPKFNDKLAEGFPLPLLKRVQLYDLGLQIHKDFLFLGANVQYMRV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 300 | N-linked_Glycosylation | YHEEGYLNFSITDDM EEECCEECEEECCCC | 21.82 | UniProtKB CARBOHYD | |
| 355 | N-linked_Glycosylation | LLNFSPGNLSVDPYM CCCCCCCCCCCCCCC | 32.31 | UniProtKB CARBOHYD | |
| 386 | N-linked_Glycosylation | FRLSVATNVSATLTF EEEEEEECEEEEEEE | 18.93 | UniProtKB CARBOHYD | |
| 394 | N-linked_Glycosylation | VSATLTFNTSKITGF EEEEEEEECCCCCCE | 37.90 | 19159218 | |
| 414 | Phosphorylation | VKVELKESKVGLFNA EEEEEECCCCCCCCH | 30.93 | 23612710 | |
| 454 | Acetylation | GFPLPLLKRVQLYDL CCCCCHHEEEEHHHC | 59.20 | 30589847 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LBP_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LBP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LBP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| FHR1_HUMAN | CFHR1 | physical | 8663389 | |
| APOA1_HUMAN | APOA1 | physical | 8663389 | |
| SMAD3_HUMAN | SMAD3 | physical | 21988832 | |
| PSA3_HUMAN | PSMA3 | physical | 21988832 | |
| SET1A_HUMAN | SETD1A | physical | 21988832 | |
| PRDX4_HUMAN | PRDX4 | physical | 21988832 | |
| TRA2A_HUMAN | TRA2A | physical | 21988832 | |
| P5CR3_HUMAN | PYCRL | physical | 21988832 | |
| T22D4_HUMAN | TSC22D4 | physical | 21988832 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-394, AND MASSSPECTROMETRY. | |